Philip Prathipati, Anup S. Pathania, Nagendra K. Chaturvedi, Subash C. Gupta, Siddappa N. Byrareddy, Don W. Coulter, & Kishore B. Challagundla. (2024). SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma. Elsevier.
Chicago Style (17th ed.) CitationPhilip Prathipati, Anup S. Pathania, Nagendra K. Chaturvedi, Subash C. Gupta, Siddappa N. Byrareddy, Don W. Coulter, and Kishore B. Challagundla. SAP30, an Oncogenic Driver of Progression, Poor Survival, and Drug Resistance in Neuroblastoma. Elsevier, 2024.
MLA (9th ed.) CitationPhilip Prathipati, et al. SAP30, an Oncogenic Driver of Progression, Poor Survival, and Drug Resistance in Neuroblastoma. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.